Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Revance Therapeutics, Inc. | 23,944 | reported | 13 Jun 2016 | tx 106+167,037−68,555 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 8.70 USD | |
| 13 Jun 2016 | SALE | Revance Therapeutics, Inc. | 1,000 | 18.25 USD | |
| 13 Jun 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 19 May 2016 | TAX_WITHHOLDING | Revance Therapeutics, Inc. | 1,320 | 17.11 USD | |
| 09 May 2016 | SALE | Revance Therapeutics, Inc. | 1,000 | 16.18 USD | |
| 09 May 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 8.70 USD | |
| 09 May 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 11 Apr 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 8.70 USD | |
| 11 Apr 2016 | SALE | Revance Therapeutics, Inc. | 1,000 | 19.11 USD | |
| 11 Apr 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 07 Mar 2016 | SALE | Revance Therapeutics, Inc. | 1,000 | 20.43 USD | |
| 07 Mar 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 8.70 USD | |
| 07 Mar 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 09 Feb 2016 | GRANT_AWARD | Revance Therapeutics, Inc. | 8,000 | 0.00 USD | |
| 09 Feb 2016 | GRANT_AWARD | Revance Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 08 Feb 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 8.70 USD | |
| 08 Feb 2016 | SALE | Revance Therapeutics, Inc. | 1,000 | 18.14 USD | |
| 08 Feb 2016 | EXERCISE | Revance Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 28 Jan 2016 | TAX_WITHHOLDING | Revance Therapeutics, Inc. | 763 | 20.30 USD | |
| 06 Jan 2016 | SALE | Revance Therapeutics, Inc. | 2,000 | 33.06 USD | |
| 06 Jan 2016 | EXERCISE | Revance Therapeutics, Inc. | 2,000 | 8.70 USD | |
| 06 Jan 2016 | EXERCISE | Revance Therapeutics, Inc. | 2,000 | 0.00 USD | deriv |
| 17 Aug 2015 | EXERCISE | Revance Therapeutics, Inc. | 3,000 | 8.70 USD | |
| 17 Aug 2015 | SALE | Revance Therapeutics, Inc. | 1,000 | 30.13 USD | |
| 17 Aug 2015 | SALE | Revance Therapeutics, Inc. | 500 | 30.27 USD |